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Abstract
Channelopathies are among the major causes of syncope or sudden cardiac death in patients
with structurally normal hearts. In these patients, the atrium, ventricle or both could be
affected and reveal different presentations. In this case, we present a patient with an appar-
ently structurally normal heart and recurrent syncope, presented as sick sinus syndrome with
atrial flutter and bidirectional ventricular tachycardia. (Cardiol J 2007; 14: 585–588)
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Introduction
Channelopathies are among the major causes
of syncope in patients with structurally normal
hearts and may have different presentations [1].
The atrium, ventricle or both could be affected by
the channelopathies, and arrhythmia in each cham-
ber may cause syncope [2]. Physicians should no-
tice the appearance of new arrhythmia in patients
with recurrent syncope and channelopathies. In this
case, we present a patient with recurrent syncope
and an apparently structurally normal heart, pre-
sented as sick sinus syndrome (SSS) with atrial flut-
ter and bidirectional ventricular tachycardia.
Case report
Interrogatory
A 24-year-old woman presented with frequent
episodes of unexplained syncope. Occasional epi-
sodes of chest discomfort before syncope were re-
ported by the patient.
Familial background
One of her cousins on her father’s side had died
suddenly. This information was extracted from her
medical file. Physical examination was unremarkable.
Electrocardiogram showed relative sinus
bradycardia without any evidence of conduction
abnormalities, ST-segment elevation in right pre-
cordial leads and QT prolongation. We did not find
significant U wave alteration.
Echocardiography revealed normal right and
left ventricular size and function. Occasional epi-
sodes of chest discomfort before syncope were re-
ported by the patient. Right and left cardiac cathe-
terization and coronary angiography showed no
abnormality. Brain computed tomographic scan and
electroencephalogram were normal. Head-up tilt
table test was negative. The key to diagnosis was
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the last 24-hour Holter monitoring. She reported
palpitation and dizziness, concomitant with atrial
flutter and a five-second pause after termination
during Holter monitoring. The patient became
a candidate for electrophysiological study and
arrhythmia radiofrequency (RF) ablation. The proce-
dure was refused by the patient. Antiarrhythmic
drug therapy (flecainide, 50 mg PO bid) started, and
a dual chamber pacemaker (Kappa KDR701,
Medtronic Inc, Minneapolis, USA) was implanted.
In the first year of follow up the patient was symp-
tom-free with no recurrence of syncope. She did not
return for pacemaker analysis and stopped taking
the drug of her own volition. She developed recur-
rent syncope during the second year of follow up;
pacemaker analysis was normal and programmed to
VVIR mode because of persistent atrial flutter. The
patient referred for arrhythmia RF ablation. Dur-
ing pacemaker analysis in our clinic, a spontaneous
episode of bidirectional ventricular tachycardia due
to emotional stress occurred (Fig. 1).
No drug consumption was reported by the pa-
tient. Clinically speaking, catecholaminergic poly-
morphic ventricular tachycardia (CPVT) strongly
suggested for her. After bidirectional isthmus block,
the atrial flutter was terminated and sinus rhythm
restored, successfully. During a study on isoprot-
erenol for evaluation of bidirectional isthmus block,
a spontaneous short episode of nonsustained poly-
morphic ventricular tachycardia was induced. Her
pacemaker was upgraded to a dual chamber implant-
able cardioverter-defibrillator. Beta-adrenergic
blockers are the most effective pharmacological
treatment in controlling arrhythmias in CPVT
patients, yet about 30% of patients still experience
cardiac arrhythmias and eventually require an im-
plantable cardioverter defibrillator. Beta-blocker
was started and increased to maximum tolerated
dose. Predischarge exercise tolerance test was nor-
mal. The patient was symptom free during six
months follow up. Unfortunately, genetic analysis is
not available in our country.
Discussion
In patients with structurally normal hearts,
channelopathies are one of the most important caus-
es of syncope or sudden cardiac death. Catecho-
laminergic bidirectional ventricular tachycardia is
observed in patients with familial CPVT, a rare ar-
rhythmic syndrome occurring in patients with ap-
parently structurally intact hearts.
Cardiac ryanodine receptor gene (RYR2) is
sometimes (not always) responsible for this ar-
rhythmia [3]. Mutations in cardiac ryanodine recep-
tors and calsequestrin genes are responsible for the
autosomal dominant and recessive variants of
CPVT, respectively.
RyR2 is located on the sarcoplasmic reticulum
and controls intracellular Ca++ release and muscle
contraction and relaxation in the heart by its capac-
ity of fast release and seizure of myoplasm of Ca++
ion, as it has just in the unions with the T system
of the plasmatic membrane, the so-called Ca++ re-
lease channel or ryanodine receptor.
Protein kinas phosphorylation dissociates the
stabilizing FKBP12.6 subunit (calstabin2) from the
RyR2 complex, resulting in increased contractility
Figure 1. Initiation of spontaneous polymorphic ventricular tachycardia (A) converted to bidirectional VT (B). Please
notice the atrial flutter with ventricular paced rhythm.
A
B
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and cardiac output. Increased RyR2 phosphorylation
and pathologically increased calstabin2 dissociation
during exercise results in aberrant diastolic calci-
um release, which may trigger ventricular arrhyth-
mias and sudden cardiac death [4].
One group has described a missense mutation
in a highly conserved region of the calsequestrin 2
gene (CASQ2) as a potential cause of the autosom-
al recessive form of CPVT [5].
This entity may induce arrhythmic events or
arrhythmias at the atrial level. CPVT patients with
RyR2 mutation might have bradycardia regardless
of the site of the mutation, which could direct mo-
lecular diagnosis in young patients without struc-
tural heart disease presenting with syncopal attacks
and slow heart rate but with normal QTc at resting
electrocardiogram [6].
Bassani et al. [7] showed the effect of ryanodine
on sinus node recovery time determined in vitro.
These results indicate that:
— a functional sarcoplasmic reticulum, albeit im-
portant for force development, does not seem
to play a major role in atrial automaticity in rats;
— disruption of cell Ca++ homeostasis by inhibi-
tion of sarcoplasmic reticulum function does
not appear to affect conduction; however, it
enhances overdrive-induced depression of si-
nusal automaticity.
Another study showed that inactivation of ry-
anodine receptor reduces, or can abolish, sinoatrial
nodal cell automaticity [8]. The biological clock of
sinoatrial nodal pacemaker cells, like that of many
other rhythmic functions occurring throughout na-
ture, involves an intracellular Ca2+ rhythm.
Interestingly, in a patient, simultaneous over-
activation and inactivation of a gene mutation have
been reported. Beaufort-Krol et al. [9] published
different aspects of a single gene SCN5A mutation.
They concluded that electrocardiographic charac-
teristics of LQT3 and Brugada syndrome show age-
dependent penetrance. A QT prolongation and con-
duction disease were present from birth onwards,
whereas ST-segment elevation only developed af-
ter 5 years. LQT3 is consistently caused by in-
creased net Na current secondary to inactivation
defects, which gives rise to persistent Na current
during phase 2. Conversely, various gating chang-
es that ultimately result in reduced Na current may
elicit Brugada syndrome, conduction disease, atrial
standstill and sinus node disease.
We could not find simultaneous gain and loss
of ryanodine receptor function in a patient in the
literature. During calcium-induced calcium-release,
the ryanodine receptor (RyR) opens and releases
large amounts of calcium from the sarcoplasmic
reticulum into the cytoplasm of the myocyte. Re-
cent experiments have suggested that cooperativ-
ity between the four monomers comprising the RyR
plays an important role in the dynamics of the over-
all receptor. Furthermore, this cooperativity can be
affected by the binding of FK506 binding protein,
and hence, modulated by adrenergic stimulation
through the phosphorylating action of protein ki-
nase A. This has important implications for heart
failure, where it has been hypothesized that RyR
hyperphosphorylation, resulting in a loss of coop-
erativity, can lead to a persistent leak and reduced
sarcoplasmic-reticula content.
Conclusions
To our best knowledge, this is the first report-
ed case of bidirectional ventricular tachycardia in
which sick sinus syndrome and atrial flutter was
observed. In patients with recurrent syncope and
a normal heart, different clinical presentations of
a single gene mutation and/or the presence of more
than one gene mutation should be expected. The
molecular diagnostics of CPVT have become in-
creasingly important because the underlying mu-
tations can be found in more than 60% of identified
CPVT patients. Along with the fact that treatment
with beta-blockers has a favourable outcome in
CPVT patients, and given the risk of sudden death,
the identification of causative mutations in CPVT
is important because it can greatly augment early
diagnosis and subsequent preventive strategies.
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